35 results

• Side Effects of Xeljanz, Rinvoq and Similar Drugs May Increase Risk of Acne: Study

  November 8, 2023

  Martha Garcia

  A new study links Xeljanz, Rinvoq and similar drugs to an increased risk of developing acne.

• Cancer Risk with Xeljanz, Other JAK Inhibitors Higher Than Among Users of Older TNF Inhibitors

  May 1, 2023

  Russell Maas

• Drugs Advertised on TV Often Have Low Therapeutic Value, Study Finds

  January 26, 2023

  Irvin Jackson

  Harvard researchers warn that drug companies spend billions of dollars advertising medications which are not as effective, and often more expensive, than other options, researchers warn.

• EMA Calls for Restricted Use of Xeljanz, Rinvoq, Similar Drugs Due to Heart, Cancer, Blood Clot and Infection Risks

  November 4, 2022

  Irvin Jackson

  European regulators urge doctors to limit the use of Xeljanz and similar drugs among certain patients more prone to heart problems and blood clots.

• Study Questions Whether Side Effects of Xeljanz, Similar Drugs, Increase Blood Clot Risks

  September 8, 2022

  Irvin Jackson

  A new study raises doubts about whether Xeljanz and similar drugs increase the risk of blood clots.

• Xeljanz Infection Risk Higher Than TNF Inhibitors: Study

  August 15, 2022

  Irvin Jackson

  Xeljanz use carries a higher infection risk than other arthritis drugs, like Humira, according to the findings of a new study.

• Skin Cancer Risk Linked to Xeljanz, Jakafi, Other JAK Inhibitors: Study

  May 18, 2022

  Irvin Jackson

  A new study links Xeljanz and similar drugs to an increased risk of skin cancer.

• Rinvoq Lawsuit Filed Against AbbVie By Investors Over Failure to Disclose Safety Concerns

  April 14, 2022

  Irvin Jackson

  AbbVie faces a class action lawsuit by investors who say the company mislead them about the safety of Rinvoq before new warning labels for cancer and heart problems were added.

• Xeljanz Stroke Lawsuit Filed Against Pfizer for Gross Negligence in Failing to Warn About Drug Risks

  April 6, 2022

  Irvin Jackson

  A Xeljanz stroke lawsuit claims Pfizer failed to adequately warn about the drug's heart risks.

• Xeljanz Lawsuit Filed Over Failure to Warn About Risk of Blood Clots, Pulmonary Embolisms

  February 24, 2022

  Irvin Jackson

  A Xeljanz lawsuit claims Pfizer misled the public about the safety of the rheumatoid arthritis drug, leading to a man suffering a life-threatening blood clot.